English | Español
Robert Hadley | Jun 19, 2017

U.S. clinical trial for chikungunya virus vaccine to begin
Carol Ostrow | Jun 18, 2017

UW, Seattle genomics center researchers identify disease proteins
Robert Hadley | Jun 18, 2017

Study may lead to development of Lassa vaccine
Ruth de Jauregui | Jun 17, 2017

Bristol-Myers Squibb, Calithera Biosciences to evaluate Opdivo, CB-839 in treating non-small cell lung cancer
Robert Hadley | Jun 17, 2017

U.S. court sides with Horizon Pharma in patent infringement claim regarding Pennsaid
Cheyenne Dickerson | Jun 16, 2017

American Cancer Society posts 6 steps to help survivors live longer lives

Robert Hadley | Jun 16, 2017

Calithera says trials indicate new drug can inhibit growth of solid tumors
Robert Hadley | Jun 16, 2017

Merck’s Keytruda shown effective in treating aggressive form of breast cancer

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’